头颈游离皮瓣重建患者多重耐药菌感染患病率
该回顾性队列纳入2009至2016年145例头颈肿瘤游离皮瓣重建并接受抗生素预防的患者,30例(20.7%)发生术后感染,其中7例为多重耐药菌感染,以MRSA最常见。抗生素谱或疗程与术后感染或MDRO发生无显著关系。
要点
- 145例中30例(20.7%)发生术后感染,7例为多重耐药菌感染。
- 抗生素谱或疗程与术后感染或MDRO发生无显著关系。
- 预防抗生素应覆盖厌氧菌和革兰阴性菌,并考虑缩短疗程。
核心结论
- 头颈游离皮瓣重建患者术后感染中多重耐药菌占少数,以MRSA最常见。
- 抗生素预防的谱或疗程与术后感染或MDRO发生无显著关系。
研究设计与样本
- 回顾性病历 review,纳入2009至2016年单中心145例头颈游离皮瓣重建患者。
主要发现
- 145例中30例(20.7%)发生术后感染。
- 感染部位为手术部位17例(55.7%)和远处13例(43.4%)。
- 7例为多重耐药菌感染,最常见为MRSA。
- 仅1例为多重耐药铜绿假单胞菌感染。
- 抗生素谱或疗程与术后感染或MDRO发生无显著关系。
关键数值与推荐
- 预防抗生素选择应覆盖厌氧菌和革兰阴性菌。
- 考虑缩短抗生素预防疗程。
- 需警惕多重耐药铜绿假单胞菌和MRSA,并以培养驱动治疗。
临床怎么用
- 对该 vulnerable 人群应选择覆盖厌氧菌和革兰阴性菌的预防抗生素。
- 可考虑缩短抗生素预防疗程而不增加感染或MDRO风险。
- 对多重耐药铜绿假单胞菌和MRSA保持警惕,依据培养结果调整治疗。
局限性
- 回顾性 chart review,证据等级为4。
- 单中心研究,样本量145例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: The purpose of this study is to evaluate the relationship between antibiotic prophylaxis and prevalence of multidrug-resistant organisms (MDRO) in patients undergoing head and neck cancer reconstruction. STUDY DESIGN: Retrospective Chart Review. METHODS: Retrospective review of patients who underwent head and neck free flap reconstruction at our institution between 2009 to 2016. RESULTS: Of the 145 patients that underwent head and neck tumor removal surgery using free tissue flaps to cover the defect and therafter received antibiotic prophylaxis, 30 (20.7%) developed postoperative surgical site (n = 17, 55.7%) or distant (n = 13, 43.4%) infections. Seven had a multidrug-resistant infection, the most common with Methicillin-Resistant Staphylococcus aureus (MRSA). There was no significant relationship between antibiotic spectrum or duration to the development of postoperative infections or MDRO. Pseudomonas and MRSA infections were low overall with only one multidrug-resistant Pseudomonas infection. CONCLUSIONS: The choice of antibiotic prophylaxis should cover organisms these patients are at highest risk for including anaerobes and Gram-negative organisms. A shorter duration of antibiotic prophylaxis should be considered given no increased risk of postoperative infection nor MDRO. Finally, one must be aware of the potential threat of multidrug-resistant Pseudomonas and MRSA amongst this vulnerable population and identity these with culture driven treatment. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:E1881-E1887, 2021.
引用
- Hamill CS, Snyder V, Sykes KJ, et al. Prevalence of Multidrug-Resistant Organisms in Patients Undergoing Free Flap Reconstruction. Laryngoscope. 2020. PMID: 33179795. doi:10.1002/lary.29268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。